Medigene AG (XTER:MDG1)
€ 1.126 0.046 (4.26%) Market Cap: 15.92 Mil Enterprise Value: 4.44 Mil PE Ratio: 0 PB Ratio: 0.81 GF Score: 46/100

Q2 2024 Medigene AG Earnings Call Transcript

Aug 14, 2024 / 01:30PM GMT
Release Date Price: €2.32
Pamela Keck
Medigene AG - Vice President, Investor Relations and Corporate Communications

Welcome, everyone, and thank you for joining us. With me today is Dr. Selwyn Ho, CEO of Medigene. Today, we announced financial results for the six months ended June 30, 2024. You can access the press release on the Investor Relations page on our website at medigene.com.

Before we get started, let's quickly run through the forward-looking statements. Please note that as part of our discussion today, management will be making forward-looking statements.

Although we believe our expectations are based on reasonable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements made on the call reflect the knowledge and information available at the time of this call. The company undertakes no obligation to update forward-looking statements. With that, I'll hand the call over to Selwyn.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot